Target intelligence / Profile preview

5S ribosomal RNA pseudogene 226 (RNA5SP226)

Target
RNA5SP226
Molecular classification
Other (non-coding RNA pseudogene)
01

Overview

5S ribosomal RNA pseudogene 226 (RNA5SP226) is a non-protein-coding, non-functional genomic sequence classified as a pseudogene of 5S ribosomal RNA. Pseudogenes arise by gene duplication or retrotransposition followed by mutation or loss of regulatory sequences, rendering them non-functional. They do not encode proteins or functional RNAs, nor do they participate in canonical biological activities. RNA5SP226 does not have known physiological, pathological, or pharmacological roles and is not relevant as a therapeutic target or biomarker. Its presence in genomic annotation reflects evolutionary history and genomic redundancy, rather than functional activity or disease association. Summary of correctness: This entry represents a miscategorization: ribosomal RNA pseudogenes are not valid molecular targets for pharmacology, disease association, or biomarker development. There is no evidence they fulfill any criteria relevant to drug targeting or functional genomics. If further specificity or correction is required, this entry should be removed or excluded from molecular target lists.

Other names
5S rRNA pseudogene 226RNA5SP226

Beyond the preview

Go deeper on 5S ribosomal RNA pseudogene 226 (RNA5SP226).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5S ribosomal RNA pseudogene 226 (RNA5SP226).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call